Basri_2023_Arch.Pharm.(Weinheim)__e2300430

Reference

Title : 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors - Basri_2023_Arch.Pharm.(Weinheim)__e2300430
Author(s) : Basri R , Fatima S , Jalil S , Imran A , Fatima N , Syed A , Bahkali AH , Iqbal J , Shafiq Z
Ref : Arch Pharm (Weinheim) , :e2300430 , 2023
Abstract : Basri_2023_Arch.Pharm.(Weinheim)__e2300430
ESTHER : Basri_2023_Arch.Pharm.(Weinheim)__e2300430
PubMedSearch : Basri_2023_Arch.Pharm.(Weinheim)__e2300430
PubMedID: 37718357

Related information

Citations formats

Basri R, Fatima S, Jalil S, Imran A, Fatima N, Syed A, Bahkali AH, Iqbal J, Shafiq Z (2023)
2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors
Arch Pharm (Weinheim) :e2300430

Basri R, Fatima S, Jalil S, Imran A, Fatima N, Syed A, Bahkali AH, Iqbal J, Shafiq Z (2023)
Arch Pharm (Weinheim) :e2300430